Purchase Order 75N94019P00557
Award Date
7/14/19
Potential Completion Date
9/12/19
Potential Value
$24K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
EI Spectra, LLC
Ultimate Awardee
Gemini Bioproducts LLC
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hailey, ID 83333, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $14,745.00 award is for in vitro diagnostic substances, reagents, test kits, and sets. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community across academic research, biotechnology, cell and gene therapy, and...
This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...
This is a $79,875 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to small business Gemini Bioproducts LLC. The contract is to provide cell culture media, sera, and other reagents in support of biomedical research and emergency response efforts. Gemini Bioproducts is a manufacturer and supplier of these products to the scientific community. This contract is set aside for small businesses. Gemini Bioproducts also...
This $61,728 firm fixed price purchase order was awarded on September 11, 2024 to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The contract supports the National Institutes of Health (NIH) Clinical Center with the supply of GemCell Plus Xeno-Free Lot H423031 products. Gemini Bioproducts has received prior sole source awards from NIH and the U.S. Department of Agriculture to provide specialized cell culture and viral transport media...
The National Institutes of Health (NIH) awarded Gemini Bioproducts, LLC a $63,530 firm fixed-price purchase order for the supply of GemCell Plus Xeno Free cell culture media. The contract has an ultimate completion date of March 13, 2025 and does not utilize a set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture products, with a history of previous federal contract awards from agencies like the U.S. Department of Agriculture and the Federal Emergency...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $57,375.00 firm-fixed-price purchase order was for the delivery of 500 mL of benchmark fetal bovine serum, a critical cell culture component used in biomedical research. This order is part of NIAID's ongoing procurement of specialized cell culture media and reagents to support its diverse scientific initiatives....
This federal contract award, valued at $77,738.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Gemini Bioproducts LLC. The contract is for the procurement of a benchmark fetal bovine serum (FBS) lot to support research characterizing the infectious properties of SARS-CoV-2 variants and developing effective prophylactic and therapeutic vaccine candidates. This is a sole source award, as the specified FBS lot...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $6,165.00 firm fixed-price purchase order is for the delivery of 500 ml bottles of fetal bovine serum, a critical cell culture reagent used in biomedical research and pharmaceutical development. The contract has no set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture...
This $3,501.23 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The contract is to provide fetal bovine serum, viral...
This federal contract award, with a ceiling value of $15,800.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services. The contract was awarded to Nemametrix, Inc., a small disadvantaged business and manufacturer of goods that specializes in developing advanced technologies for biomedical research, particularly focusing on zebrafish and C. elegans animal models. The contract, which is a...